The Medicines Company to Announce Fourth-Quarter and Full-Year 2018 Financial Results on February 27

20 Feb 2019
The Medicines Company will host a conference call on Feb 27, 2019 at 8:30 AM EST to discuss Q4 2018 financial results.

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, February 27, 2019, at 8:30 a.m. EST to discuss its fourth-quarter and full-year 2018 financial results and operational developments.

The conference call may be accessed by telephone as follows:

        U.S./Canada:     (877) 407-0312
International: (201) 389-0899
Conference ID: 13687492

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

        U.S./Canada:     (877) 660-6853
International: (201) 612-7415
Conference ID: 13687492

A live audio webcast of the conference call will be available on The Medicines Company Investor Relations website. An archived webcast will be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews.

Join $MDCO on Wed, Feb 27 for #Q4FY18 results and operational developments. Conference call to begin at 8:30AM EST.

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com